Relating to abortion, including civil liability for the manufacture and provision of abortion-inducing drugs, exemptions from the Texas Citizens Participation Act and Religious Freedom Restoration Act, authorizing civil and qui tam actions, amendments to the fee-shifting statute governing abortion litigation, immunity defenses and limits on state-court jurisdiction and relief, the parens patriae standing of the attorney general, and the jurisdiction of the Fifteenth Court of Appeals; providing for severability.

89th Legislature, 1st Called Session (2025) Introduced by Jeff Leach

Texas bill expands abortion restrictions by enabling private civil lawsuits against drug manufacturers and providers while removing typical legal defenses.

Filed

#attorneygeneral(v2811) #abortion(i0005) #computers&software(s2425) #civilremedies&liabilities(i0065) #courts--civilprocedure(i0135) #crimes--againstmorals(i0180) #crimes--miscellaneous(i0200) #electronicinformationsystems(i0311) #fifteenthcourtofappeals(vm34v) #mailorder(s0386) #medicine&prescriptiondrugs(s7338) #pregnancy&childbirth(s0294) #statutesoflimitations(s0065) #woman&childprotectionact(p26oy)

Legislative bill overview

HB 30 is a comprehensive Texas abortion restriction bill that creates civil liability mechanisms for those who manufacture or provide abortion-inducing drugs. The bill exempts these provisions from certain legal defenses (Texas Citizens Participation Act and Religious Freedom Restoration Act) and establishes qui tam actions (private lawsuits on behalf of the state) to enforce restrictions. It also modifies fee-shifting rules in abortion litigation and grants the Texas Attorney General parens patriae standing to pursue cases.

Why is this important

This legislation would significantly expand enforcement mechanisms for abortion restrictions beyond criminal penalties, potentially enabling private citizens and state officials to sue manufacturers and providers. The carve-outs from typical legal defenses make it harder for defendants to dismiss cases quickly or claim constitutional protections. These provisions would create new legal and financial risks for pharmaceutical companies, healthcare providers, and potentially others in the supply chain of medication abortion.

Potential points of contention

Constitutional concerns: Federal courts have previously blocked similar state enforcement mechanisms (like Texas SB 8) under the U.S. Constitution's supremacy clause and due process protections, raising questions about enforceability

Scope and chilling effects: Broad definitions of "manufacture and provision" could deter legitimate pharmaceutical business, telehealth services, and medical practice in Texas

Fee-shifting modifications: Changes to cost-allocation rules in litigation could shift financial burdens in ways that disproportionately affect defendants versus plaintiffs, creating asymmetrical litigation incentives